[Inhibition of PI3K/AKT signaling pathway promotes the nuclear translocation of B7-H4]

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Nov;30(11):1121-4.
[Article in Chinese]

Abstract

Objective: To investigate the regulatory effect of phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) signaling pathway on the subcellular distribution of negative co-stimulatory molecule B7-H4.

Methods: The HEK293 cells transfected stably with B7-H4, named B7-H4/HEK293, were treated with the PI3K/AKT specific inhibitor LY294002 and/or the nuclear export inhibitor leptomycin B (LMB). The subcellular localization of B7-H4 in B7-H4/HEK293 was observed by immunofluorescence and confocal laser scanning microscopy (CLSM), and the expression levels of B7-H4 in membrane, cytoplasm and nuclear were detected by Western blotting.

Results: CLSM showed that LY294002 effectively induced the nuclear translocation of B7-H4 when compared with vehicle group. When the B7-H4/HEK293 cells were treated with LY294002 and LMB, more B7-H4 was translocated into nuclear. Western blotting demonstrated that after the PI3K/AKT signal pathway was inhibited by LY294002 for 24 hours, the levels of B7-H4 in cell membrane and cytoplasm decreased significantly (P<0.05), while the expression in nuclear increased significantly (P<0.05).

Conclusion: The PI3K/AKT signal pathway might inhibit the nuclear translocation of B7-H4.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus / drug effects
  • Chromones / pharmacology
  • Fatty Acids, Unsaturated / pharmacology
  • Fluorescent Antibody Technique
  • HEK293 Cells
  • Humans
  • Morpholines / pharmacology
  • Phosphoinositide-3 Kinase Inhibitors*
  • Protein Transport / drug effects
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors*
  • Signal Transduction / drug effects*
  • V-Set Domain-Containing T-Cell Activation Inhibitor 1 / metabolism*

Substances

  • Chromones
  • Fatty Acids, Unsaturated
  • Morpholines
  • Phosphoinositide-3 Kinase Inhibitors
  • V-Set Domain-Containing T-Cell Activation Inhibitor 1
  • VTCN1 protein, human
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Proto-Oncogene Proteins c-akt
  • leptomycin B